BOMBAY BURMAH TRADING CORPORATION
Back to Income Statement
|
BOMBAY BURMAH TRADING CORPORATION Last 5 Year Revenue History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹17,109 Cr | ₹16,623 Cr | ₹14,507 Cr | ₹13,396 Cr | ₹11,889 Cr |
What is the latest Revenue of BOMBAY BURMAH TRADING CORPORATION ?
Year | Revenue |
---|---|
Mar2024 | ₹17,109 Cr |
Mar2023 | ₹16,623 Cr |
Mar2022 | ₹14,507 Cr |
Mar2021 | ₹13,396 Cr |
Mar2020 | ₹11,889 Cr |
How is Revenue of BOMBAY BURMAH TRADING CORPORATION Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹17,109 Cr | 2.92 | |
Mar2023 | ₹16,623 Cr | 14.58 | |
Mar2022 | ₹14,507 Cr | 8.29 | |
Mar2021 | ₹13,396 Cr | 12.67 | |
Mar2020 | ₹11,889 Cr | - |
Compare Revenue of peers of BOMBAY BURMAH TRADING CORPORATION
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BOMBAY BURMAH TRADING CORPORATION | ₹13,083.3 Cr | 5.8% | 9.3% | 17.2% | Stock Analytics | |
KAVERI SEED COMPANY | ₹6,823.4 Cr | 7.9% | 33% | 99.2% | Stock Analytics | |
VENKYS (INDIA) | ₹2,348.0 Cr | 5.5% | 4.4% | 3.5% | Stock Analytics | |
BOMBAY SUPER HYBRID SEEDS | ₹1,304.3 Cr | 0.6% | -4.3% | -47.8% | Stock Analytics | |
MANGALAM GLOBAL ENTERPRISE | ₹489.4 Cr | 7.6% | 4.5% | NA | Stock Analytics | |
INDO US BIOTECH | ₹307.6 Cr | -10.4% | -24.8% | -40.9% | Stock Analytics |
BOMBAY BURMAH TRADING CORPORATION Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BOMBAY BURMAH TRADING CORPORATION | 5.8% |
9.3% |
17.2% |
SENSEX | -1.3% |
4.2% |
3.6% |
You may also like the below Video Courses